Fit for the Lung?
Advances in engineered particles and the subsequent reduction in the API mass required to achieve a therapeutic dose can lead to a reduction in side effects.

Using Ultrasonic Cleaning for Equipment and Tooling
Ultrasonic cleaning of solid-dosage tooling and other equipment, such as filling-machine valves and nozzles, is more effective than hand cleaning.

Advertisement: Natoli introduces the NP-RD20, an automated single station, cGMP and CE compliant mobile lab press. Use the RD20 to manufacture single tablets or test tablet parameters during research and development. It features programmable precompression parameters and dwell time, as well as Data Acquisition capabilities to collect and track test results, including compression curve and elasticity in single, bi-layer, and multi-layer tablets.Learn more

Targeting Different Off-Shore Destinations
Annual study shows geographic proximity not a factor in CMO selection.

Baxter International Plans to Open R&D Center for Baxalta
Baxter International announced it will form a R&D center in Cambridge, Massachusetts for its new biopharmaceutical company, Baxalta.

Advertisement: API Characterization for a Speedy and Successful Formulation Strategy September 18, 2014 at 11:00 AM EDT To Register Free: www.pharmtech.com/strategy

AMAG Acquires Lumara Health for Over $1 Billion
AMAG Pharmaceuticals announced the acquisition of women’s health brand, Lumara Health, for $675 million, with an additional contingency of up to $350 million.

Advertisement: Systematic and Efficient Analytical Method Development for A Speedy Clinical Product Development October 15, 2014 at 11:00 AM EDT To Register Free: www.pharmtech.com/Efficient

FDA and NIH Win Award for IP Licensing of Meningitis Vaccine
Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.

Catalent and Cingulate Therapeutics to Collaborate on New ADHD Formulation
Formulation will utilize Catalent’s OSDrC OptiDose multicore drug-delivery platform.

Advertisement: Risk-Assessment Strategy for Validating Environmental Monitoring Software Determine What to Test and Learn How to Defend Your Rationale October 2, 2014 at 1:00 PM EDT Click here to Register.

NIH Funds Tissue Chip for Drug Screening
NIH continues funding for tissue chips to be used in the development of therapeutics.

Acorda Acquires Biopharmaceutical Company Civitas Therapeutics
Acorda Therapeutics acquired Civitas Therapeutics for $525 million, giving Acorda all the rights to CVT-301, a Phase III candidate for off episodes of Parkinson's disease.

Advertisement: The Global Quality Workflow: Making the Transition from Manual to Automated Compliance Processes Tuesday, September 30, 2014 at 11:00 AM EDT To Register Free: www.pharmtech.com/manual

FDA Releases REMS Report
FDA report details risk mitigation projects.

USP Supports WHO Biologics Naming Proposal
USP expresses its support for a consensus-based global approach to the naming of biologics.